Imaging CRO Market Overview
Imaging CRO market was valued at US$ 5.6 Billion in 2024 and is projected to grow at a CAGR of 7.20% to reach US$ 11.1 Billion by 2034.
[PDF] The Imaging CRO Market (Contract Research Organization) has become a major asset to clinical trial team because medical imaging is becoming primary & surrogate end-points in clinical trials. WORLDCARE CLINICAL, IXICO plc., ICON plc., WuXi AppTec, Labcorp, The Micron Group are some of the largest imaging CROs.
Imaging CRO Market Drivers & Restraints
Growing Complexity of Clinical Trials to fuel market growth
In today’s digital world, modern clinical trials require advanced imaging techniques such as computed tomography, magnetic resonance imaging and positron emission tomography where, Imaging CROs offer the necessary services with expertise and well-advanced infrastructure for complex imaging requirements.
For instance, according to ACRP (Association of Clinical Research Professionals), the clinical trial complexity levels has shown unrelenting increase due to larger global scope, use of more sophisticated scientific designs, and increased focus on highly targeted patient populations have intensified major challenges in executing those trials.
Cost and Time Efficiency to Fuel Market Growth
Many startups and emerging pharmaceutical companies do not have well-advanced infrastructure and thus, outsourcing provides them more time-efficient and cost-effective imaging services as compared to in-house imaging capabilities.
Restrains:
However, logistical & supply chain challenges and massive installation costs has hampered the demand for Imaging CRO Market growth.
Imaging CRO Market Segmentations & Regional Insights
Imaging CRO Market Segmentation:
Imaging CRO Market is segmented based on Services Offered, Imaging Modality, Application, End-Users and Region.
Services Offered Insight
On the basis of Services Offered, Imaging CRO Market is segmented into Image Collection & Quality Control, Imaging Acquisition & Protocol Development, Digital Image Conversion, Application Design, Support & Maintenance, and Others.
Imaging Modality Insight
On the basis of Imaging Modality, Imaging CRO Market is segmented into Magnetic Resonance Imaging, Computed Tomography Scan, Positron Emission Tomography, and Others.
Application Insight
On the basis of Application, Imaging CRO Market is segmented into Oncology, Cardiovascular, Neurology, Ophthalmology, and Others.
End-Users Insights
On the basis of End-Users, Imaging CRO Market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Medical Device Manufacturers, and Others.
Imaging CRO Market Regional Insights:
On region the Imaging CRO Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America market is estimated to witness a significantly high revenue share over the forecast period due to rising prevalence of chronic diseases, continuous technological development, increased number of clinical trials, and strong presence of major players.
Recent Development:
Strategic Acquisitions and Partnership News,
- In September 2021, WorldCare Clinical (WCC), a worldwide imaging core lab and leader in medical imaging & event adjudication solutions for clinical trials, acquired DARC (Digital Angiography Reading Center), the world’s premier ophthalmology imaging core lab.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Billion & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Services Offered - Image Collection & Quality Control, Imaging Acquisition & Protocol Development, Digital Image Conversion, Application Design, Support & Maintenance, and Others By Imaging Modality - Magnetic Resonance Imaging, Computed Tomography Scan, Positron Emission Tomography, and Others By Application - Oncology, Cardiovascular, Neurology, Ophthalmology, and Others By End-Users - Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Medical Device Manufacturers, and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034
Imaging CRO Market Competitive Landscape & Key Players
The key players operating the Imaging CRO Market includes, Parexel International Corporation, IXICO Plc., WorldCare Clinical, Radiant Sage LLC., Labcorp Drug Development, WuXi AppTec, The Micron Group, Imaging Endpoints, Medspace Holdings Inc., Biomedical Systems Corporation and Others.
Imaging CRO Market Highlights
FAQs
The Imaging CRO Market is segmented into Services Offered, Imaging Modality, Application, End-Users and Region.
By region, the Imaging CRO Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.
The key players operating the Imaging CRO Market includes, Parexel International Corporation, IXICO Plc., WorldCare Clinical, Radiant Sage LLC., Labcorp Drug Development, WuXi AppTec, The Micron Group, Imaging Endpoints, Medspace Holdings Inc., Biomedical Systems Corporation and Others.
Imaging CRO market was valued at US$ 5.6 Billion in 2024 and is projected to grow at a CAGR of 7.20% to reach US$ 11.1 Billion by 2034.